Cover Image
市場調查報告書

斑塊型乾癬:全球臨床實驗檢討

Plaque Psoriasis (Psoriasis Vulgaris) Global Clinical Trials Review, H2, 2014

出版商 GlobalData 商品編碼 318823
出版日期 內容資訊 英文 132 Pages
訂單完成後即時交付
價格
Back to Top
斑塊型乾癬:全球臨床實驗檢討 Plaque Psoriasis (Psoriasis Vulgaris) Global Clinical Trials Review, H2, 2014
出版日期: 2014年10月31日 內容資訊: 英文 132 Pages
簡介

本報告提供斑塊型乾癬的臨床試驗相關的基本資料和數據,提供您實驗數量及受驗者的募集情況,各階段趨勢,臨床試驗的主要製藥企業及研究機關簡介等資訊。

簡介

  • 斑塊型乾癬
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 亞太地區主要5個國家的臨床實驗數量
    • 歐洲主要5個國家的臨床實驗數量
    • 北美主要國家的臨床實驗數量
    • 中東·非洲主要5個國家的臨床實驗數量
    • 中南美主要5個國家的臨床實驗數量

G7各國臨床實驗數量:免疫疾病治療藥臨床實驗上斑塊型乾癬所佔的比例

G7各國的各階段臨床實驗數量

G7各國臨床實驗數量:各進展狀況

E7各國臨床實驗數量:免疫疾病治療藥臨床實驗上斑塊型乾癬所佔的比例

E7各國的各階段臨床實驗數量

E7各國臨床實驗數量:各進展狀況

各階段臨床實驗數量

  • 進行中的臨床實驗:各階段

各進展狀況臨床實驗數量

臨床實驗的目標達成情形

未完成的臨床實驗數量

一定期間所採用的實驗對像

贊助商類別的臨床實驗數量

有潛力的贊助商

斑塊型乾癬治療藥臨床實驗的主要參與企業

有潛力的藥劑

最新臨床實驗新聞 斑塊型乾癬

臨床實驗簡介

  • 主要企業臨床實驗概要
    • The LEO Foundation
    • Johnson & Johnson
    • Amgen Inc.
    • Pfizer Inc.
    • AbbVie Inc.
    • Maruho
    • Novartis AG
    • Galderma S.A.
    • Merck & Co., Inc.
    • Astellas Pharma Inc.
  • 有代表性的研究機關·醫院臨床實驗概要
    • Guangdong Provincial Hospital of Traditional Chinese Medicine
    • University of California, San Francisco
    • Mount Sinai Hospital
    • Medical University of Vienna
    • Rockefeller University
    • Dresden University of Technology
    • Tehran University of Medical Sciences
    • Peking University People's Hospital
    • Chang Gung Memorial Foundation
    • Postgraduate Institute of Medical Education and Research

5個有代表性的臨床實驗簡介

附錄

目錄
Product Code: GDHC2404CTIDB

GlobalData's clinical trial report, "Plaque Psoriasis (Psoriasis Vulgaris) Global Clinical Trials Review, H2, 2014" provides data on the Plaque Psoriasis (Psoriasis Vulgaris) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Plaque Psoriasis (Psoriasis Vulgaris). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Plaque Psoriasis (Psoriasis Vulgaris). This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Plaque Psoriasis (Psoriasis Vulgaris)
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Five Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Five Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Plaque Psoriasis (Psoriasis Vulgaris) to Immunology Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Plaque Psoriasis (Psoriasis Vulgaris) to Immunology Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Plaque Psoriasis (Psoriasis Vulgaris)
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Plaque Psoriasis (Psoriasis Vulgaris) Therapeutics Clinical Trials
  • Prominent Drugs
  • Latest Clinical Trials News on Plaque Psoriasis (Psoriasis Vulgaris)
    • Oct 16, 2014: New Analyses of Oral OTEZLA (Apremilast) Presented at EADV Show Efficacy in Difficult-to-Treat Areas of Moderate to Severe Plaque Psoriasis
    • Oct 10, 2014: Oral OTEZLA (apremilast) Data Presented at EADV Show Improved Measures of Health-Related Quality of Life and Work Productivity in Patients with Moderate to Severe Plaque Psoriasis
    • Oct 08, 2014: Amgen Announces Positive Top-Line Results From Phase 3 Study Evaluating The Efficacy And Safety Of Biosimilar Candidate ABP 501 Compared With Adalimumab In Patients With Moderate-To-Severe Plaque Psoriasis
    • Oct 01, 2014: Novartis showcases dermatology leadership on International Urticaria Day announcing new data to be presented at EADV 2014
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • The LEO Foundation
      • Clinical Trial Overview of The LEO Foundation
      • Johnson & Johnson
      • Clinical Trial Overview of Johnson & Johnson
      • Amgen Inc.
      • Clinical Trial Overview of Amgen Inc.
      • Pfizer Inc.
      • Clinical Trial Overview of Pfizer Inc.
      • AbbVie Inc.
      • Clinical Trial Overview of AbbVie Inc.
      • Maruho Co., Ltd.
      • Clinical Trial Overview of Maruho Co., Ltd.
      • Novartis AG
      • Clinical Trial Overview of Novartis AG
      • Galderma S.A.
      • Clinical Trial Overview of Galderma S.A.
      • Merck & Co., Inc.
      • Clinical Trial Overview of Merck & Co., Inc.
      • Astellas Pharma Inc.
      • Clinical Trial Overview of Astellas Pharma Inc.
    • Clinical Trial Overview of Top Institutes / Government
      • Guangdong Provincial Hospital of Traditional Chinese Medicine
      • Clinical Trial Overview of Guangdong Provincial Hospital of Traditional Chinese Medicine
      • University of California, San Francisco
      • Clinical Trial Overview of University of California, San Francisco
      • Mount Sinai Hospital
      • Clinical Trial Overview of Mount Sinai Hospital
      • Medical University of Vienna
      • Clinical Trial Overview of Medical University of Vienna
      • Rockefeller University
      • Clinical Trial Overview of Rockefeller University
      • Dresden University of Technology
      • Clinical Trial Overview of Dresden University of Technology
      • Tehran University of Medical Sciences
      • Clinical Trial Overview of Tehran University of Medical Sciences
      • Peking University People's Hospital
      • Clinical Trial Overview of Peking University People's Hospital
      • Chang Gung Memorial Foundation
      • Clinical Trial Overview of Chang Gung Memorial Foundation
      • Postgraduate Institute of Medical Education and Research
      • Clinical Trial Overview of Postgraduate Institute of Medical Education and Research
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Plaque Psoriasis (Psoriasis Vulgaris) Therapeutics, Global, Clinical Trials by Region, 2014*
  • Plaque Psoriasis (Psoriasis Vulgaris) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Plaque Psoriasis (Psoriasis Vulgaris) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Plaque Psoriasis (Psoriasis Vulgaris) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014*
  • Plaque Psoriasis (Psoriasis Vulgaris) Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Plaque Psoriasis (Psoriasis Vulgaris) Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Plaque Psoriasis (Psoriasis Vulgaris) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2014*
  • Plaque Psoriasis (Psoriasis Vulgaris) Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014*
  • Proportion of Plaque Psoriasis (Psoriasis Vulgaris) to Immunology Clinical Trials, G7 Countries (%), 2014*
  • Plaque Psoriasis (Psoriasis Vulgaris) Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Plaque Psoriasis (Psoriasis Vulgaris) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Plaque Psoriasis (Psoriasis Vulgaris) to Immunology Clinical Trials, E7 Countries (%), 2014*
  • Plaque Psoriasis (Psoriasis Vulgaris) Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Plaque Psoriasis (Psoriasis Vulgaris) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Plaque Psoriasis (Psoriasis Vulgaris) Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Plaque Psoriasis (Psoriasis Vulgaris) Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Plaque Psoriasis (Psoriasis Vulgaris) Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Plaque Psoriasis (Psoriasis Vulgaris) Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Plaque Psoriasis (Psoriasis Vulgaris) Therapeutics, Global, Suspended Clinical Trials, 2014*
  • Plaque Psoriasis (Psoriasis Vulgaris) Therapeutics, Global, Withdrawn Clinical Trials, 2014*
  • Plaque Psoriasis (Psoriasis Vulgaris) Therapeutics, Global, Terminated Clinical Trials, 2014*
  • Plaque Psoriasis (Psoriasis Vulgaris) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Plaque Psoriasis (Psoriasis Vulgaris) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Plaque Psoriasis (Psoriasis Vulgaris) Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Plaque Psoriasis (Psoriasis Vulgaris) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Plaque Psoriasis (Psoriasis Vulgaris) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Plaque Psoriasis (Psoriasis Vulgaris) Therapeutics Clinical Trials Market, Global, Clinical Trials by The LEO Foundation, 2014*
  • Plaque Psoriasis (Psoriasis Vulgaris) Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2014*
  • Plaque Psoriasis (Psoriasis Vulgaris) Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2014*
  • Plaque Psoriasis (Psoriasis Vulgaris) Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014*
  • Plaque Psoriasis (Psoriasis Vulgaris) Therapeutics Clinical Trials Market, Global, Clinical Trials by AbbVie Inc., 2014*
  • Plaque Psoriasis (Psoriasis Vulgaris) Therapeutics Clinical Trials Market, Global, Clinical Trials by Maruho Co., Ltd., 2014*
  • Plaque Psoriasis (Psoriasis Vulgaris) Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014*
  • Plaque Psoriasis (Psoriasis Vulgaris) Therapeutics Clinical Trials Market, Global, Clinical Trials by Galderma S.A., 2014*
  • Plaque Psoriasis (Psoriasis Vulgaris) Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2014*
  • Plaque Psoriasis (Psoriasis Vulgaris) Therapeutics Clinical Trials Market, Global, Clinical Trials by Astellas Pharma Inc., 2014*
  • Plaque Psoriasis (Psoriasis Vulgaris) Therapeutics Clinical Trials Market, Global, Clinical Trials by Guangdong Provincial Hospital of Traditional Chinese Medicine, 2014*
  • Plaque Psoriasis (Psoriasis Vulgaris) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Francisco, 2014*
  • Plaque Psoriasis (Psoriasis Vulgaris) Therapeutics Clinical Trials Market, Global, Clinical Trials by Mount Sinai Hospital, 2014*
  • Plaque Psoriasis (Psoriasis Vulgaris) Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of Vienna, 2014*
  • Plaque Psoriasis (Psoriasis Vulgaris) Therapeutics Clinical Trials Market, Global, Clinical Trials by Rockefeller University, 2014*
  • Plaque Psoriasis (Psoriasis Vulgaris) Therapeutics Clinical Trials Market, Global, Clinical Trials by Dresden University of Technology, 2014*
  • Plaque Psoriasis (Psoriasis Vulgaris) Therapeutics Clinical Trials Market, Global, Clinical Trials by Tehran University of Medical Sciences, 2014*
  • Plaque Psoriasis (Psoriasis Vulgaris) Therapeutics Clinical Trials Market, Global, Clinical Trials by Peking University People's Hospital, 2014*
  • Plaque Psoriasis (Psoriasis Vulgaris) Therapeutics Clinical Trials Market, Global, Clinical Trials by Chang Gung Memorial Foundation, 2014*
  • Plaque Psoriasis (Psoriasis Vulgaris) Therapeutics Clinical Trials Market, Global, Clinical Trials by Postgraduate Institute of Medical Education and Research, 2014*

List of Figures

  • Plaque Psoriasis (Psoriasis Vulgaris) Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Plaque Psoriasis (Psoriasis Vulgaris) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Plaque Psoriasis (Psoriasis Vulgaris) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Plaque Psoriasis (Psoriasis Vulgaris) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014*
  • Plaque Psoriasis (Psoriasis Vulgaris) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Plaque Psoriasis (Psoriasis Vulgaris) Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Plaque Psoriasis (Psoriasis Vulgaris) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2014*
  • Plaque Psoriasis (Psoriasis Vulgaris) Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014*
  • Proportion of Plaque Psoriasis (Psoriasis Vulgaris) to Immunology Clinical Trials, G7 Countries (%), 2014*
  • Plaque Psoriasis (Psoriasis Vulgaris) Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Plaque Psoriasis (Psoriasis Vulgaris) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Plaque Psoriasis (Psoriasis Vulgaris) to Immunology Clinical Trials, E7 Countries (%), 2014*
  • Plaque Psoriasis (Psoriasis Vulgaris) Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Plaque Psoriasis (Psoriasis Vulgaris) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Plaque Psoriasis (Psoriasis Vulgaris) Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Plaque Psoriasis (Psoriasis Vulgaris) Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Plaque Psoriasis (Psoriasis Vulgaris) Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Plaque Psoriasis (Psoriasis Vulgaris) Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Plaque Psoriasis (Psoriasis Vulgaris) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Plaque Psoriasis (Psoriasis Vulgaris) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Plaque Psoriasis (Psoriasis Vulgaris) Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Plaque Psoriasis (Psoriasis Vulgaris) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Plaque Psoriasis (Psoriasis Vulgaris) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top